Cochran Christopher P. 4
4 · Coeptis Therapeutics Holdings, Inc. · Filed Jan 9, 2024
Insider Transaction Report
Form 4
Cochran Christopher P.
Director
Transactions
- Purchase
Common Stock
2024-01-05$0.77/sh+7,000$5,390→ 37,000 total
Footnotes (1)
- [F1]Includes 30,000 shares of common stock that are issuable upon exercise of options that are or will become exercisable in the next 60 days.